MIRANDA FARIS: Open Payments
NPI 1659903144 · DEMOTTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 61 payments from 19 companies in 2025. Trend: 2023 $1,249 · 2024 $1,322 · 2025 $1,207
Food & beverage: $1,192Education: $15
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $261 |
| Axsome Therapeutics, Inc. | 4 | $121 |
| Otsuka America Pharmaceutical, Inc. | 5 | $108 |
| Corium, LLC | 4 | $102 |
| Novo Nordisk Inc | 5 | $98 |
| PFIZER INC. | 5 | $91 |
| Vanda Pharmaceuticals Inc. | 2 | $63 |
| Exact Sciences Corporation | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 4 | $59 |
| Lilly USA, LLC | 2 | $46 |
Products named: VRAYLAR, Auvelity, REXULTI, Azstarys, NURTEC ODT, FANAPT, QULIPTA, UBRELVY.
Industry payments across IN — which companies pay providers there.
